[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100314295":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":27,"centralContacts":51,"locations":60,"responsibleParty":80,"collaborators":27,"id":82,"slug":27,"hasResults":83,"nctId":84,"briefTitle":85,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":88,"sex":89,"minAge":90,"maxAge":27,"enrollmentInfo":91,"targetDuration":27,"studyType":94,"phases":95,"briefSummary":97,"conditions":98,"keywords":100,"overallStatus":63,"whyStopped":27,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"University Hospital, Rouen","OTHER",[8,19],{"label":9,"type":6,"description":10,"interventionNames":11},"Alcoholic exposure group","Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire",[12,13,14,15,16,17,18],"Behavioral: ASQ parental questionnaire","Behavioral: Development scales","Behavioral: Scale of Conners","Behavioral: SCQ Questionnaire","Procedure: Blood sample (mother)","Procedure: Cord blood sample","Procedure: Placenta sample",{"label":20,"type":6,"description":10,"interventionNames":21},"Control",[12,13,14,15,16,17,18],[23,28,32,35,39,44,48],{"type":24,"name":25,"description":25,"armGroupLabels":26,"otherNames":27},"BEHAVIORAL","ASQ parental questionnaire",[9,20],null,{"type":24,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"Development scales","WPPSI - IV and NEPSY development scales",[9,20],{"type":24,"name":33,"description":33,"armGroupLabels":34,"otherNames":27},"Scale of Conners",[9,20],{"type":24,"name":36,"description":37,"armGroupLabels":38,"otherNames":27},"SCQ Questionnaire","SCQ questionnaire",[9,20],{"type":40,"name":41,"description":42,"armGroupLabels":43,"otherNames":27},"PROCEDURE","Blood sample (mother)","Blood sample (mother) before delivery",[9,20],{"type":40,"name":45,"description":46,"armGroupLabels":47,"otherNames":27},"Cord blood sample","Cord blood sample after delivery",[9,20],{"type":40,"name":49,"description":49,"armGroupLabels":50,"otherNames":27},"Placenta sample",[9,20],[52,57],{"name":53,"role":54,"phone":55,"phoneExt":27,"email":56},"POURCHER","CONTACT","02 32 88 82 65","cecile.pourcher@chu-rouen.fr",{"name":58,"role":54,"phone":55,"phoneExt":27,"email":59},"BLOT","julien.blot@chu-rouen.fr",[61],{"facility":62,"status":63,"city":64,"state":27,"zip":65,"country":66,"countryCode":67,"cosmosGeoPoint":68,"geoPoint":73,"contacts":74},"UH ROUEN","RECRUITING","Rouen","76000","France","FR",{"type":69,"coordinates":70},"Point",[71,72],1.09932,49.44313,{"lat":72,"lon":71},[75,76,77],{"name":53,"role":54,"phone":55,"phoneExt":27,"email":56},{"name":58,"role":54,"phone":55,"phoneExt":27,"email":59},{"name":78,"role":79,"phone":27,"phoneExt":27,"email":27},"MARRET","PRINCIPAL_INVESTIGATOR",{"type":81,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100314295",false,"NCT03371641","In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions","ALCOBRAIN","Inclusion Criteria:\n\nMother:\n\n* Pregnant woman (monofetal or twin pregnancy, whatever the parity)\n* Age\\> or = to 18 years\n* Person affiliated to a social security system\n* Person who read and understood the information form and signed the consent form\n\n  * Alcohol exposure group Chronic consumption of at least 30 g of alcohol per week or acute consumption of \"binge drinking\" type during pregnancy (knowing that a unit of 10 g of pure alcohol corresponds to 25 cl of beer 4 ° 5, 10 cl of wine at 12 °, 3 cl of whiskey, 7 cl of Porto ...)\n  * Control group No alcohol consumption during pregnancy\n  * Child Informed parents and written consent signed by the father and mother for the child's participation in this research (unless one of the parents does not have parental authority)\n\nExclusion Criteria:\n\n* Female under 18\n* Pregnant woman with clinical suspicion of pre-eclampsia and \u002F or HELLP syndrome\n* Person deprived of liberty by an administrative or judicial decision or protected major subject (under tutorship or curatorship)\n* Patient participating in another interventional trial or who participated in another interventional trial during pregnancy",true,"FEMALE","18 Years",{"count":92,"type":93},60,"ESTIMATED","INTERVENTIONAL",[96],"NA","This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.",[99],"Fetal Alcohol Syndrome",[99,101,102,103,104,105],"Pregnancy","Biomarker","PlGF","Cognitive development","Behavior troubles","2026-02-04",{"date":108,"type":109},"2026-02-06","ACTUAL",{"date":111,"type":109},"2017-01-27",{"date":113,"type":93},"2026-03-27",{"name":5,"class":6},1]